Literature DB >> 6228271

X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174.

H D Ochs, J L Sullivan, R J Wedgwood, J K Seeley, K Sakamoto, D T Purtilo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6228271

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


× No keyword cloud information.
  6 in total

Review 1.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

Review 2.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

Review 3.  XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.

Authors:  Stuart G Tangye
Journal:  J Clin Immunol       Date:  2014-08-02       Impact factor: 8.317

4.  Mapping the X-linked lymphoproliferative syndrome.

Authors:  J C Skare; A Milunsky; K S Byron; J L Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 5.  X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.

Authors:  Neelam Panchal; Claire Booth; Jennifer L Cannons; Pamela L Schwartzberg
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

6.  Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.

Authors:  Cindy S Ma; Nathan J Hare; Kim E Nichols; Loic Dupré; Grazia Andolfi; Maria-Grazia Roncarolo; Stephen Adelstein; Philip D Hodgkin; Stuart G Tangye
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.